Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents

An experimental bivalent meningococcal outer membrane vesicle (OMV) vaccine (B:4:P1.19,15 and B:4:P1.7-2,4) has been developed to provide wide vaccine coverage particularly of the circulating strains in Europe. A randomized, controlled phase II study (study identification number, 710158/002; Clinica...

詳細記述

保存先:
書誌詳細
主要な著者: Boutriau, Dominique, Poolman, Jan, Borrow, Ray, Findlow, Jamie, Domingo, Javier Diez, Puig-Barbera, Joan, Baldó, José María, Planelles, Victoria, Jubert, Angels, Colomer, Julia, Gil, Angel, Levie, Karin, Kervyn, Anne-Diane, Weynants, Vincent, Dominguez, Francisco, Barberá, Ramon, Sotolongo, Franklin
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2007
主題:
Vaccine Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797715/
https://ncbi.nlm.nih.gov/pubmed/17065257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00230-06
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料